Weatherwax Bio develops induced-proximity medicines that utilize targeted molecular interactions to enhance therapeutic efficacy. This approach addresses the limitations of traditional drug delivery methods by improving the precision and effectiveness of treatments for various diseases.
Funding
$16M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional drug discovery methods often struggle to address proteins and enzymes considered "undruggable," limiting therapeutic options for various diseases. Current drug delivery methods lack the precision needed to effectively modulate protein function and biology.
Solution
General Proximity is developing next-generation proximity medicines that leverage targeted molecular interactions to control biology and enhance therapeutic efficacy. Their platform utilizes an unbiased effector discovery engine to identify proximity mechanisms for specific targets, enabling the development of highly efficacious therapeutics. By manipulating the proximity of target and effector proteins, General Proximity aims to achieve precise control over protein function, including activation, refolding, relocalization, and degradation. This approach allows for the creation of novel therapeutics for targets previously considered beyond the reach of medicine, addressing limitations in current drug discovery and delivery methods. The company's technology facilitates the development of generalized, mechanism-agnostic proximity-based therapies.
Target Audience
General Proximity's primary target audience includes researchers and pharmaceutical companies focused on drug discovery and development, particularly those working on challenging or previously undruggable targets in areas such as longevity, neurodegeneration, and metabolic disease.
Features
- Unbiased effector discovery platform for identifying proximity mechanisms
- Targeted molecular interactions to modulate protein function
- Ability to control protein activation, refolding, relocalization, and degradation
- Development of therapeutics for previously "undruggable" targets
- Generalized, mechanism-agnostic proximity discovery engine